{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T12:17:57Z","timestamp":1768133877594,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016466","name":"State of New Jersey Division of Mental Health and Addiction Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016466","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004844","name":"New Jersey Department of Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.josat.2023.209028","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:25:57Z","timestamp":1680233157000},"page":"209028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine\/naloxone"],"prefix":"10.1016","volume":"149","author":[{"given":"Anna","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc L.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Chesin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Borys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamsee","family":"Chaguturu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209028_bb0005","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2021"},{"issue":"1","key":"10.1016\/j.josat.2023.209028_bb0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1078345816685311","article-title":"Death after jail release","volume":"23","author":"Alex","year":"2017","journal-title":"Journal of Correctional Healthcare"},{"issue":"1","key":"10.1016\/j.josat.2023.209028_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ajad.13069","article-title":"Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine\/naloxone","volume":"30","author":"Antoine","year":"2021","journal-title":"The American Journal on Addictions"},{"issue":"20","key":"10.1016\/j.josat.2023.209028_bb0020","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.2020.4272","article-title":"Securing the safety net and protecting public health during a pandemic: Medicaid\u2019s response to COVID-19","volume":"233","author":"Bachireddy","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2023.209028_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"9","key":"10.1016\/j.josat.2023.209028_bb0030","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209028_bb0035","article-title":"Reconsidering the usefulness of adding naloxone to buprenorphine","volume":"11","author":"Blazes","year":"2020","journal-title":"Frontiers in Psychology"},{"issue":"3","key":"10.1016\/j.josat.2023.209028_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1360-0443.2002.00058.x","article-title":"Factors associated with non-fatal heroin overdose: Accessing the effect of frequency and route of heroin administration","volume":"97","author":"Brugal","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209028_bb0045","series-title":"CCENDU alert: changes related to COVID-19 in the illegal drug supply and access to services and resulting health harms","year":"2020"},{"issue":"102722","key":"10.1016\/j.josat.2023.209028_bb0050","article-title":"Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?","volume":"79","author":"Carlson","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209028_bb0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: Motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209028_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2023.209028_bb0065","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","article-title":"Mortality among opiate users: Opioid maintenance therapy, age and causes of death","volume":"104","author":"Clausen","year":"2009","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.josat.2023.209028_bb0070","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.annemergmed.2019.04.019","article-title":"Factors for misuse of prescribed opioids: A systematic review and meta-analysis","volume":"74","author":"Cragg","year":"2019","journal-title":"Annals of Emergency Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209028_bb0075","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/ADM.0000000000000679","article-title":"Opioid policy changes during the COVID-19 pandemic - and beyond","volume":"14","author":"Davis","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209028_bb0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3122\/jabfm.2017.04.170112","article-title":"Prescription opioid use among adults with mental health disorders in the United States","volume":"30","author":"Davis","year":"2017","journal-title":"The Journal of the American Board of Family Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209028_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5694\/j.1326-5377.2009.tb02729.x","article-title":"Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation","volume":"191","author":"Degenhardt","year":"2009","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.josat.2023.209028_bb0090","series-title":"Letter to DEA qualifying practitioners","year":"2020"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209028_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.forsciint.2006.02.047","article-title":"Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis","volume":"168","author":"Druid","year":"2007","journal-title":"Forensic Science International"},{"issue":"4","key":"10.1016\/j.josat.2023.209028_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/aje\/kwr318","article-title":"Mortality among young injection drug users in San Francisco: A 10-year follow-up of the UFO study","volume":"175","author":"Evans","year":"2012","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.josat.2023.209028_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"6 Pt 2","key":"10.1016\/j.josat.2023.209028_bb0110","article-title":"Achieving integration in mixed methods designs-principles and practices","volume":"48","author":"Fetters","year":"2013","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2023.209028_bb0115","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2021.306256","article-title":"COVID-19 and the drug overdose crisis: Uncovering the deadliest months in the United States, January\u2013July 2020","author":"Friedman","year":"2021","journal-title":"American Journal of Public Health"},{"issue":"7","key":"10.1016\/j.josat.2023.209028_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255396","article-title":"Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study","volume":"16","author":"Galarneau","year":"2021","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.josat.2023.209028_bb0125","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in BaltimoreMaryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Journal of Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.josat.2023.209028_bb0130","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/ADM.0000000000000853","article-title":"Barriers to care experienced by patients who inject drugs during the COVID-19 pandemic: A qualitative analysis","volume":"16","author":"Gleason","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"16","key":"10.1016\/j.josat.2023.209028_bb0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2020.18543","article-title":"The opioid epidemic during the COVID-19 pandemic","volume":"324","author":"Haley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209028_bb0140","series-title":"NCHS Data Brief, no 428","article-title":"Drug overdose deaths in the United States, 1999\u20132020","author":"Hedegaard","year":"2021"},{"key":"10.1016\/j.josat.2023.209028_bb0145","series-title":"NCHS data brief, no 394","article-title":"Drug overdose deaths in the United States, 1999-2019","author":"Hedegaard","year":"2020"},{"issue":"61","key":"10.1016\/j.josat.2023.209028_bb0150","first-page":"1","article-title":"Convergent and sequential synthesis designs: Implications for conducting and reporting systematic reviews of qualitative and quantitative evidence","volume":"6","author":"Hong","year":"2017","journal-title":"Systematic Reviews"},{"issue":"87","key":"10.1016\/j.josat.2023.209028_bb0155","first-page":"1","article-title":"The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: A systematic review of observational studies and analysis of public health surveillance data","volume":"16","author":"Imtiaz","year":"2021","journal-title":"Substance Abuse Treatment, Prevention and Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209028_bb0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2014.10.003","article-title":"Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors","volume":"26","author":"Johnson","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209028_bb0165","series-title":"Medicaid emergency authority tracker: Approved state actions to address COVID-19","year":"2021"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209028_bb0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209028_bb0175","first-page":"5","article-title":"Buprenorphine \u2013 background to its development as a treatment for opiate dependence","volume":"121","author":"Lewis","year":"1992","journal-title":"NIDA Research Monograph Index"},{"issue":"108158","key":"10.1016\/j.josat.2023.209028_bb0180","article-title":"A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose","volume":"120","author":"Linas","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2023.209028_bb0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addictive Medicine"},{"key":"10.1016\/j.josat.2023.209028_bb0190","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis","volume":"24","author":"Ma","year":"2018","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2023.209028_bb0195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyl in the opioid street market: Desired or imposed?","volume":"114","author":"Mars","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209028_bb0200","series-title":"Administrative bulletin","article-title":"Buprenorphine guidelines","year":"2007"},{"key":"10.1016\/j.josat.2023.209028_bb0205","series-title":"Office of Drug Monitoring & Analysis Quarterly Report, July 1 2021 - September 30, 2021","year":"2021"},{"key":"10.1016\/j.josat.2023.209028_bb0210","series-title":"Changes in Access to Medication Treatment During COVID-19 Telehealth Expansion and Disparities in Telehealth Use for Medicare Beneficiaries With Opioid Use Disorder","author":"Ng","year":"2022"},{"key":"10.1016\/j.josat.2023.209028_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2014.09.517","article-title":"The misuse, abuse and diversion of opioid replacement therapies among street abusers","volume":"146","author":"Novak","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2023.209028_bb0220","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.mayocp.2020.10.011","article-title":"Substance use disorders and telehealth in the COVID-19 pandemic era: A new outlook","volume":"95","author":"Oesterle","year":"2020","journal-title":"Mayo Clinical Proceedings"},{"issue":"113407","key":"10.1016\/j.josat.2023.209028_bb0225","article-title":"Psychological factors associated with substance use initation during the COVID-19 pandemic","volume":"293","author":"Rodgers","year":"2020","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.josat.2023.209028_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajem.2020.12.047","article-title":"Impact of a shelter-in-place order during the COVID-19 pandemic on the incidence of opioid overdoses","volume":"41","author":"Rosenbaum","year":"2021","journal-title":"American Journal of Emergency Medicine"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209028_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","article-title":"Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management","volume":"97","author":"Roux","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209028_bb0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugpo.2018.05.004","article-title":"Quantity fluctuations of illicitly used opioids and overdose risk","volume":"58","author":"Rowe","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209028_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers","volume":"29","author":"Schuman-Olivier","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209028_bb0250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"145","key":"10.1016\/j.josat.2023.209028_bb0255","article-title":"Buprenorphine use and risk of abuse and diversion","volume":"3","author":"Soyka","year":"2014","journal-title":"Advanced Pharmacoepidemiology & Drug Safety"},{"key":"10.1016\/j.josat.2023.209028_bb0260","series-title":"FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency","year":"2020"},{"issue":"19","key":"10.1016\/j.josat.2023.209028_bb0265","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"9120","key":"10.1016\/j.josat.2023.209028_bb0270","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(97)10101-5","article-title":"Death from heroin overdose: Findings from hair analysis","volume":"351","author":"Tagliaro","year":"1998","journal-title":"The Lancet"},{"issue":"102880","key":"10.1016\/j.josat.2023.209028_bb0275","first-page":"1","article-title":"Safer opioid distribution in response to the COVID-19 pandemic","volume":"82","author":"Tyndall","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"108124","key":"10.1016\/j.josat.2023.209028_bb0280","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transferring to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209028_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amepre.2021.02.026","article-title":"Association between buprenorphine for opioid use disorder and mortality risk","volume":"61","author":"Vakkalanka","year":"2021","journal-title":"American Journal of Preventative Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209028_bb0290","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"16","key":"10.1016\/j.josat.2023.209028_bb0295","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/jama.2020.17694","article-title":"Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak","volume":"324","author":"Wainwright","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209028_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108770","article-title":"Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder","volume":"139","author":"Williams","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209028_bb0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209028_bb0310","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10826080903080664","article-title":"Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South WalesAustralia","volume":"45","author":"Winstock","year":"2010","journal-title":"Substance Use and Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209028_bb0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:49:15Z","timestamp":1757432955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":63,"alternative-id":["S2949875923000784"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209028","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine\/naloxone","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209028"}}